✦ LIBER ✦

Coronary stenting without predilatation: A clinical routine with Jomed delivery system

✍ Scribed by Josef Veselka; David Tesar; Martin Mates

Book ID: 101317604
Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 17 KB
Volume: 46
Category: Article
ISSN: 1522-1946
DOI: 10.1002/(sici)1522-726x(199901)46:1<121::aid-ccd36>3.0.co;2-b

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Direct coronary stenting without predila

Direct coronary stenting without predilatation: A new therapeutic approach with a special balloon catheter design

✍ Figulla, Hans R. ;Mudra, Harald ;Reifart, Nicolaus ;Werner, Gerald S. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Coronary stenting is the primary therapeutic option for many coronary lesions, after the risk of subacute stent thrombosis and bleeding complications has been reduced by antithrombotic regimens and improved stent expansion. It would be desirable to shorten the procedure and the duration of ischemia,

A randomized study of direct coronary st

A randomized study of direct coronary stent delivery compared with stenting after predilatation: The NIR future trial

✍ John A. Ormiston; Mark W.I. Webster; Peter N. Ruygrok; John M. Elliott; Mark B. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 2 views

Clinical application of a new palmaz-sch

Clinical application of a new palmaz-schatz coronary stent delivery system with a short (8 mm) nonarticulated stent

✍ Wong, Philip H. C. ;Wong, C. M. ;Ko, Patrick T. H. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 494 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB

Comparison of Everolimus-Eluting and Pac

Comparison of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients Undergoing Multilesion and Multivessel Intervention: The SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) Randomized Trials

✍ Dean J. Kereiakes; Krishnankutty Sudhir; James B. Hermiller; Paul C. Gordon; Joa 📂 Article 📅 2010 🏛 American College of Cardiology 🌐 English ⚖ 939 KB